CASE NAME: Federal Trade Commission v. Amare Global Holdings, Inc., et al.
CASE NO.: 2:26-cv-05900
JURISDICTION: United States District Court, Central District of California
FILED ON: June 2, 2026
CLASS DEFINITION: Not a class action; enforcement action brought by the Federal Trade Commission on behalf of the public.

SUMMARY:
According to the complaint, the Federal Trade Commission alleges that Amare Global Holdings, Inc. and its executives engaged in a widespread deceptive marketing scheme involving dietary supplements and a multi-level marketing (MLM) business model. The lawsuit claims that defendants falsely promoted their products as capable of treating serious mental health conditions such as depression, anxiety, and ADHD, while also misleading consumers about the income they could earn as brand partners. The FTC asserts that these claims were not supported by reliable scientific evidence and that most participants in the MLM earned little to no income, despite representations suggesting otherwise.

ALLEGATIONS:
The lawsuit alleges that Amare operates a nationwide MLM business selling dietary supplements marketed as “mental wellness” products. These include products such as “Happy Juice,” “Kids Mood+,” and “Kids Happy Juice,” which are promoted as affecting the “gut-brain axis” and influencing neurotransmitters like serotonin and dopamine. According to the complaint, defendants claim these effects lead to improvements in mood, focus, and mental health conditions.

However, the FTC alleges that these health claims are false, misleading, or unsubstantiated. The complaint states that defendants repeatedly represented that their products could treat or alleviate conditions such as depression, anxiety, and ADHD, including in children. As illustrated in the social media examples on pages 15–18, brand partners and company representatives claimed the products could “normalize dopamine and serotonin,” reduce anxiety and depression by significant percentages, and even allow consumers to stop taking prescription medications.

The complaint further alleges that these claims were widely disseminated through social media platforms such as Instagram, TikTok, Facebook, and YouTube by both the company and its network of “brand partners.” According to the FTC, Amare trained and encouraged these individuals to promote the products and provided them with marketing materials, while failing to adequately monitor or stop misleading claims. The examples shown on pages 16–17 include posts claiming dramatic improvements in mental health, weight loss, and overall well-being, which the FTC alleges lack scientific support.

In addition to health claims, the lawsuit alleges that Amare made deceptive earnings representations to recruit new brand partners into its MLM structure. The complaint states that defendants promoted the opportunity as a way to earn substantial income, including claims that participants could make at least $500 per month or operate “seven-figure businesses.” However, according to the complaint, internal data showed that only a small percentage of participants earned that amount, and a typical brand partner earned approximately $25 per month before expenses.

The FTC also alleges that Amare’s leadership knowingly engaged in this conduct despite prior regulatory actions. Two key individuals, Shawn Talbott and Patrick Hintze, were already subject to prior FTC orders prohibiting deceptive or unsubstantiated claims. The complaint alleges that they nevertheless continued to make or facilitate similar claims through Amare’s marketing and sales network.

The lawsuit further claims that Amare used “word play” and indirect language to avoid regulatory scrutiny, encouraging brand partners to make implied health claims without explicitly using prohibited terms. According to the complaint, even when such claims violated company policies, Amare failed to take meaningful enforcement action and instead continued to promote high-performing brand partners who made these representations.

Overall, the FTC alleges that Amare’s conduct constitutes unfair and deceptive acts and practices in violation of the FTC Act. The agency seeks a permanent injunction, monetary relief, and other remedies to prevent further alleged misconduct and to address harm to consumers.